Suresh S. Ramalingam, MD, FASCO (@ramalingammd) 's Twitter Profile
Suresh S. Ramalingam, MD, FASCO

@ramalingammd

Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.

ID: 61662547

linkhttps://winshipcancer.emory.edu/suresh-ramalingam calendar_today31-07-2009 02:03:08

1,1K Tweet

5,5K Takipçi

981 Takip Edilen

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Physicians and scientists from Winship will present new cancer research findings and offer expert perspectives as session leaders at the world's largest clinical cancer research meeting, the 2024 ASCO Annual Meeting in Chicago, May 31 – June 4. #ASCO24 brnw.ch/21wKfFm

NEJM (@nejm) 's Twitter Profile Photo

Presented at #ASCO24: Among patients with EGFR-mutated lung cancer after chemoradiotherapy, 65% of patients who received osimertinib were alive without progression at 2 years, as compared with 13% of those who received placebo. Full LAURA trial results: nej.md/451OXwi

Presented at #ASCO24: 

Among patients with EGFR-mutated lung cancer after chemoradiotherapy, 65% of patients who received osimertinib were alive without progression at 2 years, as compared with 13% of those who received placebo. Full LAURA trial results: nej.md/451OXwi
BioAscend (@bioascend) 's Twitter Profile Photo

Don't miss these exciting sessions at the 18th Annual Atlanta Lung Cancer Symposium (#ALCS2024) on October 26, 2024. Network with colleagues, participate in interactive polling, & obtain #CME credit. Learn more & register here: loom.ly/hF48dNM

Don't miss these exciting sessions at the 18th Annual Atlanta Lung Cancer Symposium (#ALCS2024) on October 26, 2024.

Network with colleagues, participate in interactive polling, & obtain #CME credit.

Learn more & register here: loom.ly/hF48dNM
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Ever wondered why cancer is called "cancer"? 🤔 Discover the fascinating history and evidence behind the name in this free-to-access commentary from Dr. Konstantine Panegyres of University of Melbourne. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

Ever wondered why cancer is called "cancer"? 🤔 Discover the fascinating history and evidence behind the name in this free-to-access commentary from Dr. Konstantine Panegyres of <a href="/UniMelb/">University of Melbourne</a>. 

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

🎉Registration is now open for the #Winship5K! 🏃‍♀️ This event is dedicated to fighting against cancer 💪 and we invite everyone, whether you prefer to run or walk, to join us. Mark your calendars 📅 for Saturday, September 28th and register today: winship5k.emory.edu

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

📣 Introducing Direct to CANCER, our expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for scope or priority reasons. Learn more: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… Suresh S. Ramalingam, MD, FASCO Carissa Gilman Wiley Oncology & Hematology

📣 Introducing Direct to CANCER, our expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for scope or priority reasons. Learn more: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… <a href="/RamalingamMD/">Suresh S. Ramalingam, MD, FASCO</a> <a href="/chickybird/">Carissa Gilman</a> <a href="/WileyOnc_Hem/">Wiley Oncology & Hematology</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

📣 We recently launched Direct to CANCER, our expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for scope or priority reasons. Learn more: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert

📣 We recently launched Direct to CANCER, our expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for scope or priority reasons. 

Learn more: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… 

<a href="/oncoalert/">OncoAlert</a>
Emory Alumni (@emoryalumni) 's Twitter Profile Photo

There are so many moving @WinshipatEmory stories like this one from Rebecca Lancaster. Help others like her by participating or donating to the #Winship5K: bit.ly/3XrKCkj.

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

🎙️ New CancerSpeak episode alert! This episode dives into recent advances in #CervicalCancer treatment and research. Hear from survivor and patient advocate Linda Ryan, who shares her powerful story of her clinical trial experience. cancerspeak.podbean.com/e/top-advances… OncoAlert #gyncsm

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

We’re excited to welcome Ravi B. Parikh, MD (Ravi B. Parikh), an acclaimed physician-scientist and expert in health care artificial intelligence and machine learning, as medical director of the Winship Data and Technology Applications Shared Resource. ➡️ brnw.ch/21wMiZu

We’re excited to welcome Ravi B. Parikh, MD (<a href="/ravi_b_parikh/">Ravi B. Parikh</a>), an acclaimed physician-scientist and expert in health care artificial intelligence and machine learning, as medical director of the Winship Data and Technology Applications Shared Resource. ➡️ brnw.ch/21wMiZu
Jacob Berchuck (@jberchuck) 's Twitter Profile Photo

🚀 Excited to share that I’ve joined Emory School of Medicine & Winship Cancer Institute of Emory University to launch The Berchuck Lab. Our research is focused on using liquid biopsy to improve outcomes for people living with cancer. We’re hiring for several key roles! Learn more & apply: theberchucklab.org

PeerView (@peerview) 's Twitter Profile Photo

Remember to join us at #WCLC24 on Sept. 7 at 15:30 PDT for our #NSCLC live in-person & virtual symposium on #EGFR targeted therapy & #immunotherapy. Please tweet your questions in advance and follow PeerView for more #MedEd content! bit.ly/24Stage3LungT Suresh S. Ramalingam, MD, FASCO